Ventyx Biosciences (VTYX) Ownership - Who owns Ventyx Biosciences?
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune, and neurodegenerative disorders... Show more
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. VTYX showed earnings on August 07, 2025. You can read more about the earnings report here.